74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Prestige Consumer Healthcare
Open
SectorHealthcare
63.66 1.18
Overview
Share price change
24h
Min
62.48
Max
64.2
Income | -2.7M 47M |
|---|---|
Sales | -47M 250M |
P/E Sector Avg | 14.893 35.739 |
Profit margin | 19.022 |
Employees | 600 |
EBITDA | -5.8M 80M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +43.22% upside |
Next Earnings | 6 Nov 2025 |
|---|
Market Cap | -524M 3.1B |
|---|---|
Previous open | 62.48 |
Previous close | 63.66 |
News Sentiment
By Acuity
13%
87%
16 / 371 Healthcare
Prestige Consumer Healthcare Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Prestige Consumer Healthcare Forecast
Price Target
By TipRanks
43.22% upside
12 Months Forecast
Average 90 USD 43.22%
High 100 USD
Low 80 USD
Based on 3 Wall Street analysts offering 12 month price targets forPrestige Consumer Healthcare - Dist in the last 3 months.
Sentiment
By Acuity
16 / 371 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Live chat